Nobelpharma

News & Press Release

2018-10-15Press Release

Launching Sales of Jemina^® Tablets, a Treatment for Dysmenorrhea[31 KB]
2018-10-10Press Release

BIO JAPAN 2018 Shigeki Shimasaki, Vice President and COO, to give a presentation
Session on Regenerative Medicine [S-9], lead presentation by Dr. Tasuku Honjo (2018 Nobel Laureate in Physiology or Medicine), President, Foundation for Biomedical Research and Innovation at Kobe,
Date: Thursday, October 11, 2018 15: 00 ~ 17: 00 Venue: Pacifico Yokohama F203 ・ F204
2018-08-15Press Release

Lunabell^® Compound Tablets LD and ULD Authorized Generic[65 KB]
2018-07-02Press Release

Jemina^® tablets（NPC-16）Approved in Japan for the Treatment of Dysmemorrhea
2018-07-02Press Release

Announcing Sales Launch of TITANBRIDGE^® First Medical Device to Receive SAKIGAKE Designation Medical Device for the Treatment of Adductor Spasmodic Dysphonia[99 KB]
2018-06-06Press Release

Launch of RAPALIMUS^® GEL 0.2% SAKIGAKE Designation & Orphan Drug Designation Treatment for Angiofibroma in Tuberous Sclerosis Complex[154 KB]
2018-05-31Press Release

Announcement of Personnel Changes[43 KB]
2018-05-15Press Release

Announcement of Private Placement of Shares to MEDIPAL HOLDINGS CORPORATION[118 KB]
2018-03-26Press Release

Announcement of Personnel Changes[65 KB]
2018-03-26Press Release

Marketing Approval Granted for RAPALIMUS GEL 0.2% (mTOR inhibitor), SAKIGAKE Designation & Orphan Drug Designation to Treat Angiofibroma in Tuberous Sclerosis Complex[51 KB]